Clinical Trials

Inclusion Criteria:

Each patient must meet all of the following inclusion criteria to be enrolled in the study:

• Patient is an adult (18 years of age or older).

• Treatment with Envarsus XR® or immediate-release, twice-daily tacrolimus has been indicated by patient’s transplant care team. 

• Patient is a recipient of a deceased or living donor kidney transplant.
• Patient is able to comply with study procedures for the entire length of the study.
• Patient has been informed about the study survey and has signed an informed consent form.

Exclusion Criteria:

Patients meeting any of the following exclusion criteria are not to be enrolled in the study:

• Patient is unable or unwilling to complete study patient reported outcome questionnaires.
• Patient is currently receiving azathioprine
• Patient is currently receiving an mTOR inhibitor (sirolimus, everolimus)
• Patient is currently receiving belatacept .
• Patient has received investigational immunosuppression 1 month prior to transplant or post-transplant.
• Patient is in a setting where a professional care taker is responsible for dispensing subject’s medication.